OHSU Funding Alerts: Week of January 27, 2022

Each week, OHSU Research Development compiles a list of funding opportunities from internal sources, the government and private foundations. We publish the list here every Thursday. A pdf of the list is also available.

Featured Opportunities 
Multidisciplinary Association of American Medical Colleges Herbert W. Nickens Faculty Fellowship
What: 
Supports junior faculty members who demonstrate leadership potential in addressing inequity in medical education and health care
Who should apply: Full-time assistant professors who have held their position from no earlier than July 1, 2019 and have received only one appointment as assistant professor

Award: $25,000/one year

Deadline: Internal submission due: Feb. 1, 2022; Application due: April 1, 2022, 8:59 p.m. PT
Apply through the CAP


Cancer Kuni Foundation Imagination Grants for Cancer Research
What: 
Supports advanced research for the diagnosis and treatment of cancer with an emphasis on clinical applications of promising drug and technological advances, or emerging research, or a new approach that demonstrates potential for the diagnosis or treatment of cancer 
How to apply: 
The OHSU Foundation must submit all proposals on behalf of OHSU; submit a Notice of Intent form by Jan. 26, and OHSU Foundation will provide detailed instructions on how to apply
Who should apply: Investigators at all career stages with a research interest in cancer diagnosis and treatment
Award: Up to $75,000/one year
Deadline: Notice of Intent form due: Jan. 26, 2022; Application due: Feb. 21, 2022, midnight PT
This organization is on the President’s List; submit a notice of intent form before applying


CancerV Foundation Adult Translational Cancer Research (Early Detection of Cancer)
What: 
Supports translational research projects within the scope of adult cancer research, specifically in the focus area of early detection of cancer
Who should apply: Tenure-track or tenured faculty with a research interest in adult early cancer detection
Award: Up to $600,000/up to three years
Deadline: Internal submission due: Feb. 14, 2022; Nomination due: Feb. 28, 2022, 2 p.m. PT; Application due: March 24, 2022, 2 p.m. PT
Apply through the CAP
This organization is on the President’s List; submit a notice of intent form before applying


Multidisciplinary The Pew Charitable Trusts 2023 Scholars Program
What: 
Two programs are combined in this competition: the Pew Scholars Program in the Biomedical Sciences and the Pew-Stewart Scholars for Cancer Research Program; both are intended for early-career research with an emphasis on interdisciplinary projects
Who should apply: Early-career assistant professors with a research interest in biomedical studies or cancer studies
Award: $300,000/four years
Deadline: Internal submission due: March 23, 2022; Nomination due: May 18, 2022; Application due: Sept. 8, 2022 for Cancer Scholars and Sept. 1, 2022 for Biomedical Scholars
Apply through the CAP

MultidisciplinaryChan Zuckerberg Initiative and National Academies of Sciences, Engineering, and Medicine Science Diversity Leadership Award
What: 
Recognizes the leadership and scientific accomplishments of outstanding early- to mid-career researchers who have a record of promoting diversity, equity, and inclusion in their scientific fields through their outreach, mentoring, and teaching
Who should apply: Investigators who perform research relevant to the biomedical sciences and who started their first independent laboratory no earlier than January 1, 2012
Award: Up to $1.15 million/up to five years
Deadline: May 19, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Internal Opportunities 

CancerOHSU Knight Cancer Institute Prostate Cancer Spore
What: Competitive renewal for KCI’s Pacific Northwest Prostate Cancer Specialized Program of Research Excellence funded by the NIH; the SPORE will likely submit four major projects and include two to four support cores, and it is anticipated that a subset of the four projects will be continuation projects and a subset will be entirely new projects
How to apply: Submissions are a one-page proposal, and the template is linked in this OHSU Now post
Who should apply: Investigators with an interest in prostate cancer research
Award: Estimated to be $200,000 per year   
Deadline: Jan. 30, 2022
Contact Tom Beer, M.D., professor and deputy director of the Knight Cancer Institute, if you are thinking about submitting a proposal 

Deadline extended
Cancer
Kuni Foundation Imagination Grants for Cancer Research
What: Supports advanced research for the diagnosis and treatment of cancer with an emphasis on clinical applications of promising drug and technological advances, or emerging research, or a new approach that demonstrates potential for the diagnosis or treatment of cancer
How to apply: The OHSU Foundation must submit all proposals on behalf of OHSU; submit a Notice of Intent form by Jan. 26, and OHSU Foundation will provide detailed instructions on how to apply
Who should apply: Investigators at all career stages with a research interest in cancer diagnosis and treatment
Award: Up to $75,000/one year   
Deadline: Notice of Intent form due: Feb. 1, 2022; Application due: Feb. 21, 2022, midnight PT
This organization is on the President’s List; submit a notice of intent form before applying 

MultidisciplinaryOHSU Foundation Collins Medical Trust
What: Provides seed funding for projects that advance basic or clinical medical research and will be leveraged to have a greater impact in the future through being eligible for future NIH or other substantial funding; successful proposals will highlight impact on the immediate population served, Oregon, and potential national impact and preference is given to young investigators newly embarking on their research careers who are clearly supported by their respective mentors
Who should apply: Early career investigators, including postdoctoral fellows and assistant professors, who are clearly supported by their mentors
Award: Up to $30,000/one year
Deadline:
Notice of Intent form is required; submission window starts Feb. 4, 2022 and goes through Feb. 11, 2022; Application due: April 29, 2022
Questions? Contact the
OHSU Foundation

MultidisciplinaryCascadia Data Discovery Initiative and Microsoft Cascadia Azure credit award for regional collaborations in data-intensive science
What: Supports projects involving basic, clinical, and public health research; projects that involve sharing of data sets across institutions and projects that validate new computational tools or build on existing tools are encouraged, and cancer research and infectious disease research, including COVID-related proposals, are welcomed
Who should apply: Multiple PIs are required, and at least one PI must be from Fred Hutch, BC Cancer, OHSU Knight Cancer Institute, University of Washington (UW) eScience Institute, or UBC; collaborations where at least one PI is at the assistant or associate rank and between junior and senior investigators are encouraged
Award: Up to $200,000 in Azure cloud credits/From Feb. 18 to Sept. 24, 2022
Deadline: Feb. 7, 2022, 5 p.m. PT
Send questions to
Katie Smolnycki

New this week!
Multidisciplinary
OHSU Occupational Health Sciences’ Summer Student Research Awards
What: Paid summer internships designed to introduce undergraduate students to biomedical and occupational health research
Who should apply: Students who are Oregon residents or attend college in Oregon and are working toward their first four-year degree
Award: Up to $2,500/up to 10 weeks
Deadline: Feb. 15, 2022, 5 p.m. PT
Apply through the CAP

Pediatrics OHSU Doernbecher Children’s Hospital 2022 Friends of Doernbecher Grant Program
What: Supports clinical and research projects and programs at OHSU Doernbecher Children’s Hospital; pediatric-related research projects and programs that impact children’s health are supported by the program
Who should apply: OHSU and Doernbecher faculty, clinical and research staff, graduate students, medical students, fellows and postdoctoral fellows
Award: Up to $50,000/one year
Deadline: Feb. 18, 2022, 5 p.m. PT
Apply through the CAP 

Cancer BRIDGE-C2 Center Small Grants Program
What: Small grants program held through the BRIDGE-C2 Center, an NCI-funded Implementation Science Center for Cancer Control, that aims to conduct rapid-cycle research aimed at eliminating longstanding gaps in cancer screening and prevention
Who should apply: Faculty, project scientists, research trainees, postdoctoral fellows and community practitioners at OHSU and OCHIN Inc.
Award: Up to $20,000/six months
Deadline: LOI due: March 1, 2022, 5 p.m. PT; Application due: June 15, 2022, 5 p.m. PT
Submit an LOI; send any questions about this opportunity to Sara McCrimmon

Multidisciplinary NIGMS, OHSU Research & Innovation and Vollum Institute OHSU Postbaccalaureate Research Education Program (PREP)
What: Program for recruiting and retaining Persons Excluded because of their Ethnicity or Race (PEER) postbacs for an intensive, mentored experience research experience with the goal to prepare them for pursuing a graduate degree in biomedical research
Who should apply: Researchers who have graduated or are in the process of graduating with a baccalaureate degree in a biomedically relevant science from an accredited college or university after June 1st, 2019, are US citizens, nationals or permanent residents, are not currently enrolled in a degree program and belong to a group considered to be underrepresented in the field of biomedical research; see more details
Award: Competitive research assistant salary and health benefits/one year
Deadline: March 1, 2022, 11:59 p.m. PT
Send questions to
PREPtograd@ohsu.edu
Apply through the CAP

Multidisciplinary Alliance for Visible Diversity in Science Elevate Award
What: Recognizes a member of the Oregon Health & Science University community for making effective strides in racial equity and inclusion
Who should apply: Individuals who have catalyzed positive change in cultivating a more equitable and inclusive environment within the research community; self-nominations welcome and all OHSU members can nominate
Award: $500
Deadline: Open now

Multidisciplinary ‖ OCTRI Mobile Apps for Clinical Studies (MACS)
What: 
Funding to leverage new the REDCap functionality MyCap to create mobile apps that allow clinical study participants to report outcomes/data via a smartphone; the program aims to help fill the pipeline for BIP Digital Health by allowing PIs to conduct preliminary research and obtain user experience data
Who should apply: PIs who meet OHSU Principal Investigator requirements and want to create a mobile app for clinical or commercial purposes
Award:
Up to $5,000/typically one year
Deadline: Rolling; application will close when funding for the fiscal year is exhausted
Submit your project intake form through REDCap

Multidisciplinary OHSU Fellowship for Diversity in Research
What: Funds researchers with the goal of increasing the diversity of the community of scholars devoted to academic scientific research at OHSU
Who should apply: Investigators with postdoctoral training experience looking to establish an independent academic research career; scholars who identify as underrepresented minorities, differently-abled and more are welcomed
Award: Up to $8,000 plus a stipend
Deadline: Applications accepted anytime

Public Health OHSU-PSU School of Public Health Kickstarter Awards
What: Funding to support pre-award activities that advance the preparation of high-quality grant or contract applications
Who should apply: OHSU and PSU faculty with primary appointment in OHSU-PSU School of Public Health who have an extramural RFA or other opportunity identified
Award: Between $500 and $5,000/up to six months
Deadline: Accepted on a rolling basis through March 31, 2022
Apply through the CAP

Multidisciplinary OHSU School of Medicine Exploratory Research Seed Grants
What: Supports investigators who need to work with an OHSU core or with the Pacific Northwest National Laboratory (PNNL) to develop preliminary data for an application for extramural research support
Who should apply: School of Medicine faculty in the professorial series who have not received this award within the last year
Award: Up to $5,000/one year
Deadline: Applications accepted anytime
Apply through the CAP

Limited Submission Opportunities   

MultidisciplinaryAssociation of American Medical Colleges Herbert W. Nickens Faculty Fellowship
What: Supports junior faculty members who demonstrate leadership potential in addressing inequity in medical education and health care
Who should apply: Full-time assistant professors who have held their position from no earlier than July 1, 2019 and have received only one appointment as assistant professor
Award: $25,000/one year 
Deadline: Internal submission due:
Feb. 1, 2022; Application due: April 1, 2022, 8:59 p.m. PT
Apply through the CAP

Cancer Pediatric Cancer Research Foundation Research Grants
What: Supports childhood cancer research through four grants: Basic Science Research Grants, Translational Research Grants, Emerging Investigator Fellowship Grants, and Designated Grant Programs
Who should apply: Basic and Translational grant applicants must have a PhD or MD and Emerging Investigator grant applicants must have either completed two years of their fellowship or had a position as junior faculty instructor or assistant professor for up to two years from the start of the award period
Award: For Basic: Up to $750,000/up to three years; For Translational: Up to $200,000/up to two years; For Emerging Investigator: Up to $50,000/one year; For Designated: Not listed
Deadline: Internal submission due:
Feb. 4, 2022; LOI due: March 1, 2022, 5 p.m. PT; Application due: June 1, 2022, 5 p.m. PT
Apply through the CAP

New this week!
Cancer
V Foundation Adult Translational Cancer Research (Early Detection of Cancer)
What: Supports translational research projects within the scope of adult cancer research, specifically in the focus area of early detection of cancer
Who should apply: Tenure-track or tenured faculty with a research interest in adult early cancer detection
Award: Up to $600,000/up to three years
Deadline: Internal submission due:
Feb. 14, 2022; Nomination due: Feb. 28, 2022, 2 p.m. PT; Application due: March 24, 2022, 2 p.m. PT
Apply through the CAP
This organization is on the President’s List; submit a notice of intent form before applying

Aging NIA Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) (U24 Clinical Trial Optional)
What: Coordinating Center for the Claude D. Pepper Older Americans Independence Centers program that will be a facilitator for OAIC site interactions and a conduit for translating OAIC objectives and findings to both scientific and general audiences
Who should apply: Anyone with a research interest in maintaining or restoring independence in older persons
Award: Up to $2.125 million/up to five years
Deadline: Internal submission due:
Feb. 24, 2022; LOI due: April 16, 2022 (LOI not required but highly encouraged); Application due: May 16, 2022, 5 p.m. PT
Apply through the CAP

MultidisciplinaryJosiah Macy Jr. Foundation Board Grants and President’s Grants
What: Supports educational projects that improve health by advancing the education and training of future health professionals through two grant mechanisms: Board Grants and President’s Grants
How to apply: When you submit your application through the CAP, you must also submit a Notice of Intent form to the OHSU Foundation; the Foundation will be pleased to provide guidance and editorial review (non-scientist, funder perspective) on your application
Who should apply: Applicants to either grant type must meet OHSU Principal Investigator requirements
Award: For Board Grants: Up to $300,000/up to three years; For President’s Grants: Up to $25,000/one year  
Deadline: Internal submission due:
March 1, 2022; Proposals due: Rolling
Apply through the CAP
This organization is on the President’s List; submit a notice of intent form before applying

Allergic Disease NIAID Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
What: Supports centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy and drug allergy
Who should apply: Anyone with a research interest in asthma and allergic diseases, though multiple PIs are only allowed for the Overall Program, and an investigator can serve as a PI on only one AADCRC award or application; further eligibility info in FOA
Award: Up to $4.5 million/up to five years
Deadline: Internal submission due:
March 3, 2022; LOI due: May 3, 2022 (LOI not required but highly encouraged); Application due: June 3, 2022, 5 p.m. PT
Apply through the CAP

New this week!
Multidisciplinary
The Pew Charitable Trusts 2023 Scholars Program
What: Two programs are combined in this competition: the Pew Scholars Program in the Biomedical Sciences and the Pew-Stewart Scholars for Cancer Research Program; both are intended for early-career research with an emphasis on interdisciplinary projects
Who should apply: Early-career assistant professors with a research interest in biomedical studies or cancer studies
Award: $300,000/four years   
Deadline: Internal submission due:
March 23, 2022; Nomination due: May 18, 2022; Application due: Sept. 8, 2022 for Cancer Scholars and Sept. 1, 2022 for Biomedical Scholars
Apply through the CAP

MultidisciplinaryNIGMS and ORIP High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) and Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
What: Supports groups of NIH-supported investigators to purchase or upgrade a single item of high-end, specialized, commercially available instruments or integrated systems
How to apply: OHSU is not limited in the number of applications we may submit, provided that the applications are for different types of equipment; however, internal review is required. You must submit a 1-3 page preliminary proposal that names a minimum of three major users who are PIs on active NIH research grants; additional information on proposal in CAP
Who should apply: PIs do not need to have an NIH research grant or any other research support but are expected to be an expert on the requested instrument and may be a core director or tenured or non-tenured faculty member; multiple PIs are not allowed
Award: For Shared Grants: Between $50,000 and $600,000/one year; For High-End Grants: Between $600,001 and $2 million/one year    
Deadline: Internal submission due:
March 28, 2022; Application due: June 1, 2022, 5 p.m. PT
Apply through the CAP

Merit Prizes and Awards

Neuroscience ‖ Brain Sciences 2022 Young Investigator Awards
What: Honors three young investigators in recognition of their excellence in the field of neuroscience
Who should apply: PhDs who will be under 35 years of age by the deadline, have produced ground-breaking research and made a significant contribution to the advancement of neuroscience and are nominated by senior scientists
Award: Approximately $1,644.46 (amount converted from Swiss Francs) 
Deadline: Jan. 31, 2022 

Deadline extended
Multidisciplinary
NOSTER and Science Microbiome Prize
What: Rewards innovative research by young investigators working on the functional attributes of the microbiota of any organism that has potential to contribute to our understanding of human or veterinary health and disease or to guide therapeutic interventions
Who should apply:
Researchers younger than thirty-five who have received their degree in the last 10 years; work submitted for consideration must have been performed in the past three years
Award: $25,000
Deadline: Feb. 7, 2022

Multidisciplinary PhRMA Foundation Value Assessment Challenge Awards
What: Supports research on pressing questions related to value assessment in health care through two award mechanisms, one for health equity and one for patient-centered outcomes
Who should apply:
Anyone with a research interest in health equity or patient-centered outcomes
Award: Up to $50,000
Deadline: March 1, 2022, 8:59 p.m. PT 

Neuroscience Science & PINS Prize for Neuromodulation
What: Rewards innovative research that modulates neural activity through physical (electrical, magnetic, optical) stimulation of targeted sites in the nervous system with implications for translational medicine
Who should apply:
Investigators younger than forty-five who have received their degree in the last 10 years; work submitted for consideration must have been performed in the past three years
Award: $25,000
Deadline: March 15, 2022

Cardiology McGill 2022 Louis and Artur Lucian Award for Research in Circulatory Diseases
What: Rewards outstanding research in the field of circulatory diseases by a scientific investigator or group of investigators whose contribution to knowledge in this field is deemed worthy of special recognition
Who should apply:
Researchers whose current work is in the circulatory disease field
Award: Approximately $58,426 (amount converted from CAD)
Deadline: April 1, 2022

COVID-19 Opportunities

Due to the decline in new funding opportunities related to COVID-19, we are transitioning the separate COVID-19 Funding Alerts to this space. You can still view the archive of COVID-19 Funding Alerts, and a list of still-open opportunities will be updated weekly.

MultidisciplinaryMultiple NIH Organizations Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
What: Supports research on strategies and interventions to address vaccine hesitancy, uptake and implementation among populations who experience health disparities in the US and its territories
Who should apply: Anyone with a research interest in vaccine hesitancy
Award: Dependent upon FOA you apply through        
Deadline: Open from Feb. 5, 2022 through Jan. 8, 2023 

Multidisciplinary NHLBI, NIAID and NICHD Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection
What: Supports projects that will employ existing and new clinical trial cohorts/observational cohorts to screen for co-infection, phenotype and collect biospecimens to answer COVID-19 questions outlined in the NOSI
Who should apply: Anyone with a research interest in pediatric COVID and respiratory viral co-infection
Award: Dependent upon FOA you apply through        
Deadline: Open from Feb. 5, 2022 through Sept. 8, 2025 

Rheumatology NIAMS Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
What: Announces to potential applicants to the NIAMS an interest in research on the impact of COVID-19 as related to diseases and conditions within the NIAMS mission
Who should apply: Anyone with a research interest in NIAMS-related topics and COVID-19
Award: Dependent upon FOA you apply through        
Deadline: Open from Feb. 5, 2022 through Jan. 7, 2023 

Mental Health NIMH Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research
What: Supports research to provide an evidence base to understand how mental illness contributes to COVID-19 risk and mortality, how incident mental illness develops with COVID-19, and the development of scalable interventions to meet the public mental health needs during and resulting from the pandemic
Who should apply: Anyone with a research interest in mental illness and COVID-19
Award: Dependent upon FOA you apply through         
Deadline: Open from Feb. 15, 2022 through Jan. 8, 2025

New this week!
Multidisciplinary Multiple NIH Organizations Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
What: Supports the ongoing and long-term impacts of the COVID-19 pandemic, focusing specifically on governmental policy and programmatic actions that address two specific social determinants of health: food/nutrition security and housing security
Who should apply: Anyone with a research interest in food or housing security and COVID-19
Award: Not limited/up to five years    
Deadline: LOI due: March 7, 2022 (LOI not required but highly encouraged); Application due: April 7, 2022, 5 p.m. PT 

NIH Federal Opportunities

This week the NIH released funding opportunities concerning liver cancer, alcohol use and pain management. We’ve highlighted some opportunities of potential interest below.

Multidisciplinary NIMH, NIMHD and ODP Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 Clinical Trial Optional)
What: Supports research to develop and test community-level interventions to improve minority health and reduce health disparities
Who should apply: Anyone with a research interest in community-level interventions to improve health disparities
Award: Up to $5 million/up to five years    
Deadline: LOI due: Feb. 28, 2022 (LOI not required but highly encouraged); Application due: March 28, 2022, 8:59 p.m. PT

Multidisciplinary Multiple NIH Organizations HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed)
What: Supports applications that analyze existing data and resources from humans including large, diverse national research cohorts to answer specific questions about the development of human acute or chronic pain and its management
Who should apply: Anyone with a research interest in acute or chronic pain management
Award: Up to $275,000/up to two years    
Deadline: LOI due: March 1, 2022 (LOI not required but highly encouraged); Application due: March 31, 2022, 8:59 p.m. PT

Multidisciplinary Multiple NIH Organizations Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
What: Program to recruit and retain outstanding postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators
Who should apply: Institutional PIs must be an established clinician-investigator in a relevant scientific area and capable of providing both administrative and scientific leadership to the proposed program; additional eligibility information in FOA
Award: Administrative costs, resident-investigator’s salaries, travel, and supplementary research funds/up to five years    
Deadline: March 15, 2022, 5 p.m. PT

Immunology NIAID Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U01 Clinical Trial Not Allowed) and (U19  Clinical Trial Not Allowed)
What: Supports a multi-center, cooperative program dedicated to developing, optimizing, and evaluating approaches to induce and maintain immune tolerance to allogeneic transplants in nonhuman primate models
Who should apply: Investigators may be a PI, multiple PI, or U19 Project Leader on only one application submitted in response to either RFA; additional eligibility information in RFAs (U01 and U19)
Award: Not limited/up to five years    
Deadline: LOI due: April 13, 2022 (LOI not required but highly encouraged); Application due: May 13, 2022, 8:59 p.m. PT

Cancer NCI Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
What: Supports the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research through collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology
Who should apply: Multi-PIs are strongly encouraged given the required multidisciplinary expertise for developing and characterizing state-of-the-art biomimetic tissue-engineered technologies for understanding cancer pathophysiology in the context of a testable cancer research hypothesis
Award: Up to $2 million/up to five years    
Deadline: LOI due: May 5, 2022 (LOI not required but highly encouraged); Application due: June 5, 2022, 8:59 p.m. PT

Pulmonology NHLBI and NIGMS ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed) and ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01 Clinical Trial Not Allowed)
What: Supports a consortium that will seek to understand the heterogeneity and underlying mechanisms of critical illness syndromes and recovery, specifically in adults with ARDS, pneumonia, and sepsis as well as the relationship and biological overlap among these syndromes
Who should apply: Anyone with a research interest in ARDS, pneumonia, and sepsis; for Coordinating Center, NHLBI encourages multi-PI applications, with at least one a senior statistician with demonstrated experience in coordinating large multi-site clinical research studies and another senior investigator with extensive clinical research experience and expertise in the areas of ARDS, pneumonia, and sepsis
Award: For Clinical Centers: Up to $2.075 million/up to six years; For Coordinating Center: Up to $7.35 million/up to six years    
Deadline: LOI due: May 17, 2022 (LOI not required but highly encouraged); Application due: June 17, 2022, 8:59 p.m. PT

Substance Use NIDA and ODP Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction
What: Supports research on the prevention of risky drug use behaviors and addiction to address the need for development and testing of substance use prevention strategies across the lifespan and for population subgroups at greater risk
Who should apply: Anyone with a research interest in drug use and addiction on a population-wide level
Award: Dependent upon FOA you apply through       
Deadline: Open from June 5, 2022 through May 8, 2025
 

Administrative Supplements

CancerNCI Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations with the NCI- supported PDX Development and Trial Centers Research Network (PDXNet)

Multidisciplinary NIGMS Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Activities to Enhance Mentoring in the Research Training Environment

Multidisciplinary NIGMS Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Activities to Enhance Wellness and Resiliency in the Training Environment

Multidisciplinary NIGMS Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Modules to Enhance Undergraduate Biomedical Research Training

Multidisciplinary NIGMS Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Modules to Promote Safe and Inclusive Biomedical Research Training Environments

Multidisciplinary NIGMS Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for Select NIGMS-Funded Awards

Multidisciplinary NIGMS Notice of Special Interest (NOSI): Administrative Supplements to Enhance Laboratory Safety Curriculum and a Culture of Safety in Biomedical Research Training Environments

Multidisciplinary NIGMS Notice of Special Interest (NOSI): Administrative Supplements to Enhance Program Evaluation Capacity

Requests for Information

CancerNCI Request for Information (RFI): Seeking Input from Multi-Cancer Early Detection Test Developers on Readiness for Participation in an NCI-Sponsored Clinical Utility Randomized Controlled Screening Trial

Other Federal Opportunities

Multidisciplinary NSF Molecular Foundations for Biotechnology (MFB)
Partnerships to Transform Emerging Industries

What: Supports synergistic scientific research collaborations that involve innovative machine learning methods to foster advances in research on the function of biomolecular systems and have the potential to drive innovation in biotechnology
Who should apply: Anyone with a research interest in biomolecular system function
Award: Up to $9 million to be allocated among up to six awardees/not specified      
Deadline: LOI due: Feb. 14, 2022, 5 p.m. PT; Application due: April 14, 2022, 5 p.m. PT

NeuroscienceDoD Alzheimer’s Disease Research Program Accelerating Diagnostics Research Award
What: Supports validation and implementation of innovative diagnostic modalities to better determine the trajectory, long-term outcomes, and impact of Alzheimer’s disease and related dementias following military service and/or traumatic brain injury
Who should apply: Independent investigators at or above the level of assistant professor or equivalent
Award: Up to $2.5 million/up to four years 
Deadline: Not announced yet; will be posted here again when deadline is announced

NeuroscienceDoD Alzheimer’s Disease Research Program Investigator-Initiated Research Award
What: Supports research with high innovation/impact in one of the PRARP focus areas, which are Individual, caregiver, and family support, environmental, diagnostic, and prognostic factors, and fundamental research
Who should apply: Independent investigators; if taking early-career investigator partnering PI option, PI must be a junior investigator within 10 years of their terminal degree or new to the field
Award: Up to $750,000/up to three years 
Deadline: Not announced yet; will be posted here again when deadline is announced

NeuroscienceDoD Alzheimer’s Disease Research Program Translational Research Award
What: Supports the translation of promising research into clinical application (i.e., preclinical to clinical translation) and clinical care (i.e., implementation science)
Who should apply: Independent investigators
Award: Up to $1.2 million/up to three years 
Deadline: Not announced yet; will be posted here again when deadline is announced

Private Opportunities

CancerLivestrong Foundation Solution Grants
What: Supports research focused on overlooked cancer problems, with emphasis on nutrition and mental health as they relate to cancer  
Who should apply:
anyone with a research interest in mental health or nutrition and cancer
Award: Up to $50,000/up to one year
Deadline: Feb. 13, 2022, 9:59 p.m. PT

Mental Health American Psychological Foundation F.J. McGuigan Early Career Investigator Research Grant
What: Supports research that aims to address any aspect of mental function (e.g., cognition, affect, motivation) and seeks to understand the mind from both a behavioral and neural perspective
Who should apply:
Psychologists or researchers in a related field who are no more than 10 years postdoctoral
Award: Up to $11,500/not specified
Deadline: March 1, 2022

Neuroscience Alzheimer’s Drug Discovery Foundation Diagnostics Accelerator and Target ALS Foundation Biomarker Discovery
What: Supports biomarker research targeting biomarkers that might be common to disease pathways or pathophysiologies in Alzheimer’s disease, frontotemporal degeneration and amyotrophic lateral sclerosis to facilitate biomarker discovery and validation
Who should apply: Anyone with a research interest in biomarkers for Alzheimer’s
Award: Up to $600,000/up to two years
Deadline: LOI due: March 2, 2022, 2 p.m. PT; Full application due: May 6, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Rheumatology Bay Area Lyme Foundation Emerging Leader Awards
What: Supports new and innovative projects and aim to attract new scientific talent to the field of Lyme disease  
Who should apply:
Researchers who are currently at the postdoctoral level through assistant professor level or equivalent
Award: Up to $100,000/up to one and a half years
Deadline: April 1, 2022

Pulmonology Cystic Fibrosis Foundation Impact Grants
What: Supports individuals or organizations that have developed, or would like to develop, a program or project for individuals with cystic fibrosis or their families to support them in their daily lives
Who should apply:
U.S. Citizens or permanent residents with a research interest in improving the lives of those living with cystic fibrosis
Award: Up to $10,000/up to one year with possibility for one-year renewal
Deadline: April 5, 2022, 2 p.m. PT

CancerProstate Cancer Foundation Young Investigator Awards
What: Funding to advance the career and research efforts of young prostate cancer researchers; proposed research should be high-impact, and projects focused on prostate cancer health disparities are encouraged
Who should apply:
Postdoctoral fellows, instructors, research associates, and assistant professors who are within six years of their professional degree; additional requirements listed in RFA
Award: Up to $225,000/up to three years
Deadline: April 25, 2022, noon PT

Multidisciplinary Chan Zuckerberg Initiative and National Academies of Sciences, Engineering, and Medicine Science Diversity Leadership Award
What: Recognizes the leadership and scientific accomplishments of outstanding early- to mid-career researchers who have a record of promoting diversity, equity, and inclusion in their scientific fields through their outreach, mentoring, and teaching
Who should apply:
Investigators who perform research relevant to the biomedical sciences and who started their first independent laboratory no earlier than January 1, 2012
Award: Up to $1.15 million/up to five years
Deadline: May 19, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying                                                       

Previously Published Opportunities

Federal 

January 2022

Biology NSF Dark Dimensions of the RNA Regulome (D2R2) Preliminary proposal due: Jan. 31, 2022, 5 p.m. PT; Full proposal due: Aug. 31, 2022, 5 p.m. PT

February 2022

NeuroscienceNIA Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed) LOI due: Feb. 1, 2022 (LOI not required but highly encouraged); Application due: March 3, 2022, 5 p.m. PT

Environmental Health NIEHS Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional) Application due: Feb. 1, 2022, 5 p.m. PT

Pain Management Multiple NIH Organizations HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) LOI due: Feb. 2, 2022 (LOI not required but highly encouraged); Application due: March 2, 2022, 8:59 p.m. PT

MultidisciplinaryMultiple NIH Organizations NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) LOI due: Feb. 2, 2022 (LOI not required but highly encouraged); Application due: March 2, 2022, 5 p.m. PT

Substance Use Multiple NIH Organizations Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) LOI due: Feb. 3, 2022; Application due: Feb. 18, 2022, 8:59 p.m. PT

Aging NIA Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) Deadline: Feb. 3, 2022, 5 p.m. PT

Gastroenterology NIDDK High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 – Clinical Trial Not Allowed) LOI due: Feb. 3, 2022 (LOI not required but highly encouraged); Application due: March 3, 2022, 5 p.m. PT

Endocrinology NIDDK Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required) LOI due: Feb. 3, 2021 (LOI not required but highly encouraged); Application due: March 3, 2021, 5 p.m. PT

Endocrinology NIDDK Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes – Clinical Centers (U01 Clinical Trial Not Allowed) LOI due: Feb. 3, 2022 (LOI not required but highly encouraged); Application due: March 3, 2022, 5 p.m. PT

Genomics NHGRI Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) LOI due: Feb. 4, 2022 (LOI not required but highly encouraged); Application due: March 4, 2022, 5 p.m. PT

NeuroscienceNIA and NINDS Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed) Deadline: Feb. 4, 2022, 5 p.m. PT

Substance Use NIDA Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) LOI due: Feb. 4, 2022 (LOI not required but highly encouraged); Application due: March 4, 2022, 8:59 p.m. PT

Multidisciplinary AHRQ and CQuIPS Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) and Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) Deadline: R01 due: Feb. 5, 2022, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) and (R21 Clinical Trials Not Allowed) R01 due: Feb. 5, 2022, 5 p.m. PT; R21 due: Feb. 16, 2022, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 – Basic Experimental Studies with Humans) and (R01 Clinical Trials Not Allowed) Deadline: Clinical R01 due: Feb. 5, 2022; Basic R01 due: March 5, 2022, 5 p.m. PT

Multidisciplinary Multiple NIH Organizations Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) Deadline: Feb. 5, 2022, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT

Multidisciplinary Multiple NIH Organizations Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed) Deadline: Open from Feb. 5, 2022 through Nov. 19, 2024

MultidisciplinaryMultiple NIH Organizations Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) Deadline: Feb. 5, 2022, 5 p.m. PT

CancerNCI Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Deadline: Feb. 5, 2022, 5 p.m. PT

CancerNCI Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) and (R21 Clinical Trial Not Allowed) Deadline: R01 due: Feb. 5, 2022, 5 p.m. PT; R21 due: Feb. 16, 2022, 5 p.m. PT

Cancer NCI Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment Deadline: Open from Feb. 5, 2022 through Oct. 9, 2024

MultidisciplinaryNCI and NHLBI Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity Deadline: Open from Feb. 5, 2022 through Nov. 6, 2024

Multidisciplinary NCI, NHLBI and NICHD Notice of Special Interest (NOSI): Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults Deadline: Open from Feb. 5, 2022 through May 8, 2023

Multidisciplinary NCI, NIDCR and NIMHD Notice of Special Interest (NOSI): Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities Deadline: Open from Feb. 5, 2022 through Jan. 8, 2025

Ophthalmology NEI Regenerative Medicine Clinical Trial Planning Grant (R34 – Clinical Trials Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT

MultidisciplinaryNHLBI Notice of Special Interest (NOSI): Heart, Lung, Blood and Sleep Focused Ancillary Studies to Large Ongoing Clinical Studies (Revised) Deadline: Open from Feb. 5, 2022 through May 8, 2023

Hematology NHLBI, NIA and NIDDK Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT

MultidisciplinaryNHLBI, NIA and NINDS Notice of Special Interest (NOSI): Promoting research to understand vascular contributions to cognitive impairment and dementia (VCID) Deadline: Open from Feb. 5, 2022 through May 8, 2025

Neuroscience NIA Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional) Application due: Feb. 5, 2022, 5 p.m. PT

NeuroscienceNIA and NINDS Prodromal Synaptic and Circuit Changes that Contribute to AD/ADRD Onset and Progression (R01 Clinical Trial Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT

Infectious Disease NIAID Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine Deadline: Open from Feb. 5, 2022 through Jan. 7, 2025

Immunology NIAID Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity Deadline: Open from Feb. 5, 2022 through Jan. 7, 2025

Pediatrics NICHD Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 – Clinical Trial Optional), (R03 – Clinical Trial Optional) and (R21 – Clinical Trial Optional) R01 due: Feb. 5, 2022, 5 p.m. PT; R03 and R21 due: Feb. 16, 2022, 5 p.m. PT

Pediatrics NICHD Notice of Special Interest (NOSI): Advancing Innovative Non-invasive Physiologic Monitoring To Improve Fetal Assessment Deadline: Open from Feb. 5, 2022 through May 8, 2024

Multidisciplinary NIDA and NIMH Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings Deadline: Open from Feb. 5, 2022 through Jan. 8, 2025

MultidisciplinaryNIMH Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) Deadline: R01 due: Feb 5, 2022; R21 due: Feb. 16, 2022, 5 p.m. PT

Neuroscience NINDS Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional) Application due: Feb. 5, 2022, 5 p.m. PT

NeuroscienceNINDS Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders Deadline: Open from Feb. 5, 2022 through Jan. 8, 2025

Ophthalmology NEI Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed) LOI due: Feb. 7, 2022 (LOI not required but highly encouraged); Application due: March 7, 2022, 5 p.m. PT

Cancer NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) Deadline: Feb. 8, 2021, 5 p.m. PT

Infectious Disease NIAID Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed) Application due: Feb. 8, 2022, 5 p.m. PT

Immunology NIAID Development of Microbiome-Related Approaches for Diagnosis/Mitigation/Treatment of Radiation Injuries (U01 Clinical Trial Not Allowed) Application due: Feb. 9, 2022, 5 p.m. PT

Pharmacology FDA CDER PBPK Modeling to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract (U01) Clinical Trial Optional LOI due: Feb. 11, 2022 (LOI not required but highly encouraged); Application due: March 31, 2022, 8:59 p.m. PT

MultidisciplinaryMultiple NIH Organizations HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) Application due: Feb. 11, 2022, 5 p.m. PT

NeuroscienceNIA and NINDS Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed) LOI due: Feb. 11, 2022 (LOI not required but highly encouraged); Application due: March 11, 2022, 5 p.m. PT

MultidisciplinaryNIBIB and NIMHD Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) Deadline: Feb. 11, 2022, 5 p.m. PT

MultidisciplinaryAHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Career Development Award (K01) Deadline: Feb. 12, 2022, 5 p.m. PT

Aging NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)  Deadline: Feb. 12, 2022, 5 p.m. PT

NeuroscienceMultiple NIH Organizations BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) Application due: Feb. 15, 2022, 5 p.m. PT

Pain Management NCCIH NIH-DOD-VA Pain Management Collaboratory – Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) LOI due: Feb. 15, 2022 (LOI not required but highly encouraged); Application due: March 15, 2022, 5 p.m. PT

Cardiology NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) and Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) Application due: Feb. 15, 2022, 5 p.m. PT

MultidisciplinaryNIA and NIMH Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) LOI due: Feb. 15, 2022 (LOI not required but highly encouraged); Application due: March 15, 2022, 5 p.m. PT

Multidisciplinary NIDA High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) Application due: Feb. 15, 2022, 5 p.m. PT

CancerNCI Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology Deadline: Open from Feb. 16, 2022 through May 8, 2023

MultidisciplinaryNCI, NIAMS and NIDCR Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) and (R21 Clinical Trial Optional) Deadline: Feb. 16, 2022, 5 p.m. PT

Aging NIA Notice of Special Interest (NOSI): Analyses of CALERIE Datasets and Biospecimens to Elucidate the Biological Effects and the Behavioral and Psychological Aspects of Sustained Caloric Restriction in Humans Deadline: Open from Feb. 16, 2022 through May 8, 2023

Immunology NIAID Notice of Special Interest (NOSI): Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity Deadline: Open from Feb. 16, 2022 through Jan. 7, 2025

MultidisciplinaryMultiple NIH Organizations Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 – Clinical Trials Optional) LOI due: Feb. 17, 2022 (LOI not required but highly encouraged); Application due: March 18, 2022, 8:59 p.m. PT

NeuroscienceMultiple NIH Organizations Notice of Special Interest (NOSI): BRAIN Initiative: Translation of Groundbreaking Technologies from Early-stage Development through Early Clinical Study via Blueprint MedTech Deadline: Open from Feb. 18, 2022 through June 20, 2024

Infectious Disease NIAID Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed) Application due: Feb. 18, 2022, 5 p.m. PT

Mental Health NIMH Enhanced Interpersonal Focused Strategies for Suicide Prevention Interventions (R34 Clinical Trial Required) Application due: Feb. 18, 2022, 5 p.m. PT

MultidisciplinaryNHGRI and NIBIB New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) Application due: Feb. 22, 2021, 5 p.m. PT

Endocrinology NIDDK Analysis, Technology, Leadership, Administration and Science (ATLAS) Center (U24 Clinical Trial Not Allowed) LOI due: Feb. 24, 2022 (LOI not required but highly encouraged); Application due: March 24, 2022, 5 p.m. PT

Pediatrics NICHD Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) LOI due: Feb. 28, 2022 (LOI not required but highly encouraged); Application due: March 30, 2022, 5 p.m. PT

MultidisciplinaryNICHD, NIDA and NIMH Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) and Scientific Leadership Center (UM2 Clinical Trial Optional) LOI due: Feb. 28, 2022 (LOI not required but highly encouraged); Application due: March 31, 2022, 5 p.m. PT

Multidisciplinary NICHD and ORWH Promoting Reproductive Health for Adolescents and Adults with Disabilities (R01 Clinical Trial Optional) LOI due: Feb. 28, 2022 (LOI not required but highly encouraged); Application due: March 30, 2022, 5 p.m. PT

March 2022

Biology FDA Research to support the development of alternatives to antimicrobials for use in food-producing animals (U01) Clinical Trial Not Allowed LOI due: March 1, 2022 (LOI not required but highly encouraged); Application due: April 1, 2022, 8:59 p.m. PT

Neuroscience NIH Common Fund SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required) LOI due: March 1, 2022 (LOI not required but highly encouraged); Application due: April 1, 2022, 5 p.m. PT

Neuroscience NIA Early and Late Stage Clinical Trials for the Spectrum of Alzheimer’s Disease/Alzheimer’s Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) and Pilot Studies for the Spectrum of Alzheimer’s Disease/Alzheimer’s Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) Deadline: March 4, 2022, 5 p.m. PT

Substance Use Multiple NIH Organizations HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed) Deadline: March 10, 2022, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed) LOI due: March 11, 2022 (LOI not required but highly encouraged); Application due: April 11, 2022, 5 p.m. PT

NeuroscienceNIA Notice of Special Interest (NOSI): Novel Approaches to Diagnosing and Studying Clinical Alzheimer’s Disease and Related Dementias Deadline: Open from March 11, 2022 through Nov. 13, 2024

Neuroscience NIA and NINDS Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) Deadline: March 11, 2022, 5 p.m. PT

Multidisciplinary NCI and ODP Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed) LOI due: March 20, 2022 (LOI not required but highly encouraged); Application due: May 8, 2022, 5 p.m. PT

CancerNCI Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) and Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) LOI due: March 22, 2022 (LOI not required but highly encouraged); Application due: April 22, 2022, 5 p.m. PT

Cancer NCI Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) LOI due: March 22, 2021 (LOI not required but highly encouraged); Application due: April 22, 2022, 5 p.m. PT

April 2022

Biology FDA Center for Veterinary Medicine Innovative ways to provide education on antimicrobial stewardship practices in animals (U01) Clinical Trial Not Allowed LOI due: April 1, 2022 (LOI not required but highly encouraged); Application due: May 2, 2022, 8:59 p.m. PT

HIV/AIDS NIDA, NIMH and OBSSR Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) LOI due: April 10, 2022 (LOI not required but highly encouraged); Application due: May 10, 2022, 5 p.m. PT

Aging NIA Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required) LOI due: April 14, 2022 (LOI not required but highly encouraged); Application due: June 15, 2022, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) and Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) Application due: April 18, 2022, 5 p.m. PT

Immunology NIAID Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed) LOI due: April 20, 2022 (LOI not required but highly encouraged); Application due: May 20, 2022, 5 p.m. PT

MultidisciplinaryNIDDK High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) LOI due: April 20, 2022 (six weeks before application deadline) (LOI not required but highly encouraged); Application due: June 1, 2022, 5 p.m. PT

May 2022

Cancer NCI Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) LOI due: May 7, 2022 (LOI not required but highly encouraged); Application due: June 7, 2022, 5 p.m. PT

MultidisciplinaryNHLBI Notice of Special Interest (NOSI): Examining Effects of HIV Pre-Exposure Prophylaxis (PrEP) on Heart, Lung, Blood, and Sleep Function Deadline: Open from May 7, 2022 through May 8, 2025

MultidisciplinaryNIGMS National and Regional Resources (R24 – Clinical Trial Not Allowed) LOI due: May 14, 2022 (LOI not required but highly encouraged); Application due: June 14, 2022, 5 p.m. PT

Mental Health NIMH Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional) LOI due: May 20, 2022 (LOI not required but highly encouraged); Application due: June 21, 2022, 5 p.m. PT

June 2022

Multidisciplinary Multiple NIH Organizations Risk and Protective Factors of Family Health and Family Level Interventions (R01 – Clinical Trial Optional) Deadline: June 5, 2022, 5 p.m. PT

Substance Use NIAAA Notice of Special Interest (NOSI): Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College Deadline: Open from June 5, 2022 through Sept. 8, 2025

Multidisciplinary Multiple NIH Organizations Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required), (R01 Clinical Trial Required) and (R01 Clinical Trials Not Allowed) Deadline: June 21, 2022, 5 p.m. PT

Open

NeuroscienceDoD Amyotrophic Lateral Sclerosis Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

Neuroscience DoD Autism Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

Cancer DoD Breast Cancer Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

NeuroscienceDoD Epilepsy Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

Cancer DoD Lung Cancer Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

Cancer DoD Ovarian Cancer Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

Multidisciplinary DoD Tuberous Sclerosis Complex Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

Substance Abuse NIAAA NOSI: Advances in Research for the Treatment, Services, and Recovery of Alcohol Use Disorder Deadline: Open through Sept. 8, 2023

HIV/AIDS NIMH Notice of Special Interest: Advancing Health Communication Research on HIV Prevention, Treatment and Cure Deadline: Open through March 1, 2024

Multidisciplinary NHLBI and NIEHS NOSI: Stimulating Intervention Research to Reduce Cardiopulmonary Impacts of Particulate Matter in Air Pollution among High-Risk Populations Deadline: Open through Sept. 7, 2025

Genomics  NHGRI Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) Applications are accepted by continuous receipt

Biology NSF Biophotonics Applications accepted anytime

Biology NSF Cellular and Biochemical Engineering Applications accepted anytime

Biology  NSF Dear Colleague Letter: Conferences for Building Computational Literacy in Biological Sciences Deadline: Open

MultidisciplinaryNSF Dear Colleague Letter: Pilot Projects for Cyberinfrastructure Centers of Excellence Deadline: Rolling

Biology NSF Division of Integrative Organismal Systems Core Programs Applications accepted anytime

Biology NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB) Deadline: Open

Multidisciplinary NSF Enabling Discovery through GEnomic Tools (EDGE) Deadline: Open

Biology NSF Infrastructure Innovation for Biological Research (Innovation) Deadline: Open

Biology NSF Transitions to Excellence in Molecular and Cellular Biosciences Research (Transitions) Deadline: Open

Private 

January 2022

Multidisciplinary L’Oréal USA For Women in Science Fellowship Deadline: Jan. 28, 2022, 8:59 p.m. PT

Neuroscience Parkinson’s Foundation Community Grants Deadline: Jan. 28, 2022, 8:59 p.m. PT

MultidisciplinaryAmerican Psychological Foundation Alice F. Chang Cancer Wellness Grant Deadline: Jan. 31, 2022

Psychology American Psychological Foundation Div. 37 Diane J. Willis Early Career Award Deadline: Jan. 31, 2022

CancerEvansMDS Discovery Research Grants LOI due: Jan. 31, 2022; Full application due: April 2022
This organization is on the President’s List; submit a notice of intent form before applying

Cancer EvansMDS Young Investigator Awards Deadline: Jan. 31, 2022
This organization is on the President’s List; submit a notice of intent form before applying

February 2022

NeuroscienceFRAXA Research Foundation Clinical Trial Grants Deadline: Feb. 1, 2022, 8:59 p.m. PT

Neuroscience FRAXA Research Foundation Fellowships Deadline: Feb. 1, 2022, 8:59 p.m. PT

Cancer Jane Coffin Childs Memorial Fund for Medical Research Postdoctoral Fellowship Deadline: Feb. 1, 2022

Physical Therapy Massage Therapy Foundation Research Support Grant Deadline: Feb. 1, 2022, 9:59 p.m. PT

MultidisciplinaryPatient-Centered Outcomes Research Institute Implementation Funding LOI due: Feb. 1, 2022, 2 p.m. PT; Full application due: April 12, 2022, 2 p.m. PT

Multidisciplinary PhRMA Foundation Health Outcomes Research and Translational Medicine Grants Deadline: Feb. 1, 2022, 8:59 p.m. PT

Cancer Sarcoma Foundation of America 2022 Research Grants Deadline: Feb. 1, 2022, 2 p.m. PT

Nursing National League for Nursing Nursing Education Research Grants Deadline: Feb. 3, 2022

NeuroscienceAlzheimer’s Drug Discovery Foundation Core Funding Programs LOI due: Feb. 4, 2022, 2 p.m. PT; Applications due: April 8, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Emergency Medicine Emergency Medicine Foundation Health Disparities Research Grant Deadline: Feb. 4, 2022

Emergency Medicine Emergency Medicine Foundation and Society for Academic Emergency Medicine Medical Student Research Grant Deadline: Feb. 4, 2022

Cancer Follicular Lymphoma Foundation Curative Research to Eliminate Follicular Lymphoma Awards LOI due: Feb. 4, 2022, 8:59 p.m. PT; Full application due: April 15, 2022, 8:59 p.m. PT

Nursing Johnson & Johnson Innovation Nurse-led Tech QuickFire Challenge Deadline: Feb. 4, 2022

Cancer Leukemia Research Foundation Hollis Brownstein Research Grants Program LOI due: Feb. 4, 2022, 10 a.m. PT; Applications due: April 4, 2022, 10 a.m. PT

Neuroscience Parkinson’s Foundation Movement Disorders Fellowship Deadline: Feb. 4, 2022

MultidisciplinarySouthwest National Primate Research Center Pilot Research Grants LOI due: Feb. 4, 2022; Full proposal due: March 25, 2022

Neuroscience Organization for Autism Research Graduate Research Grant Competition Deadline: Feb. 7, 2022, 8:59 p.m. PT

Gastroenterology Pfizer 2022 IBD Competitive Grant Program Deadline: Feb. 7, 2022, 8:59 p.m. PT

Surgery American Shoulder and Elbow Surgeons Foundation Research Grant Deadline: Feb. 8, 2022

MultidisciplinaryPatient-Centered Outcomes Research Institute Research Funding LOI due: Feb. 8, 2022, 2 p.m. PT; Full application due: May 3, 2022, 2 p.m. PT

Rheumatology Pfizer 2022 Rheumatology Competitive Grant Program Deadline: Feb. 8, 2022, 8:59 p.m. PT

Cancer American Society for Radiation Oncology Minority Summer Fellowship Award Deadline: Feb. 11, 2022

MultidisciplinaryDanone North America Gut Microbiome, Yogurt and Probiotics Fellowship Grant Deadline: Feb. 14, 2022

Cancer Melanoma Research Foundation Breakthrough Consortium Pilot Translational Award Deadline: Feb. 14, 2022, 2 p.m. PT

Nephrology National Kidney Foundation Young Investigator Research Grant Deadline: Feb. 14, 2022

Psychology American Psychological Foundation Dr. Christine Blasey-Ford Grant Deadline: Feb. 15, 2022

Psychology American Psychological Foundation Trauma Psychology Grant Deadline: Feb. 15, 2022

Rheumatology Pfizer 2022 Rheumatology Fellowship Deadline: Feb. 15, 2022, 8:59 p.m. PT

Cardiology American Heart Association Research Grants Deadline: Deadlines go through Feb. 16, 2022, 1 p.m. PT

Pulmonology Cystic Fibrosis Foundation Funding Opportunities Deadline: All applications due Feb. 16, 2022, 2 p.m. PT, except First and Second Year Fellowships, due March 2, 2022, 2 p.m. PT

NeuroscienceNational Multiple Sclerosis Society Therapeutic Development Opportunities Addressing Nervous System Repair in Multiple Sclerosis LOI due: Feb. 16, 2022; Full proposal due: Feb. 23, 2022

NeuroscienceNew York Stem Cell Foundation NYSCF – Robertson Neuroscience Investigator Awards Deadline: Feb. 16, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Anesthesiology Anesthesia Patient Safety Foundation Investigator Initiated Research Grants LOI due: Feb. 17, 2022, 3 p.m. PT; Full application due: August 2022

Allergies Johnson & Johnson Innovation Food Allergy Prevention QuickFire Challenge Deadline: Feb. 18, 2022

Cancer Pfizer and Lilly BRAF V600-mutant colorectal cancer: Disease education and therapy management Deadline: Feb. 18, 2022, 8:59 p.m. PT

Cancer Alex’s Lemonade Stand Foundation Pediatric Oncology Student Training Program Deadline: Feb. 21, 2022, 5 p.m. PT

Neuroscience Alzheimer’s Association APOE Biology in Alzheimer’s (ABA) Grant Program LOI due: Feb. 24, 2022, 2 p.m. PT; Full application due: May 3, 2022, 2 p.m. PT

MultidisciplinaryHuman Animal Bond Research Institute Addressing Evidence-Based Health Benefits of Human-Animal Interaction Deadline: Feb. 24, 2022, 8:59 p.m. PT

Dermatology Pfizer Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Early Career Investigators Deadline: Feb. 24, 2022, 8:59 p.m. PT

Audiology Hearing Health Foundation Emerging Research Grants Deadline: Feb. 25, 2022

Sexual Health Sexual Medicine Society of North America Young Clinicians Research Grant Deadline: Feb. 28, 2022

Neuroscience Simons Foundation Autism Research Initiative Bridge to Independence Award Deadline: Feb. 28, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

March 2022

Cardiology Abbott Fellowship Program Grants Deadline: March 1, 2021

Rheumatology Lupus Research Alliance Lupus Innovation Award LOI due: March 1, 2022, 8:59 p.m. PT; Full application due: Aug. 1, 2022, 8:59 p.m. PT

Cancer Mark Foundation Endeavor Awards Deadline: LOI due: March 1, 2022; LOI due: Aug. 2, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Physical Therapy Massage Therapy Foundation Research Award LOI due: March 1, 2022, 9:59 p.m. PT; Full application due: Aug. 1, 2022, 9:59 p.m. PT

Dermatology Milstein Medical Asian American Partnership Dermatology Research Project Award in Atopic Dermatitis Deadline: March 1, 2022, 11:59 p.m. China time

Hematology Pfizer 2022 Global Hemophilia ASPIRE Deadline: March 1, 2022, 8:59 p.m. PT

Vascular Society for Vascular Surgery Clinical Research Seed Grant Deadline: March 1, 2022, 9:59 p.m. PT

MultidisciplinaryRobert Wood Johnson Foundation Health Policy Research Scholars Deadline: March 16, 2022, noon PT
This organization is on the President’s List; submit a notice of intent form before applying

Neuroscience Simons Foundation Autism Research Initiative (SFARI) Pilot Award Deadline: March 17, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

April 2022

MultidisciplinaryChan Zuckerberg Initiative Biohub Deadline: LOI due: April 1, 2022, 5 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Neuroscience James S. McDonnell Foundation Opportunity Awards Deadline: April 1, 2022, 1:59 p.m. PT

Open

HIV/AIDS amfAR Target Grants Deadline: Rolling

Substance Abuse Charles Koch Foundation Substance Abuse Research Grants Deadline: Rolling

NeuroscienceCure SMA Newborn Screening for Spinal Muscular Atrophy Program Deadline: Rolling

Pulmonology Cystic Fibrosis Foundation Path to a Cure: Industry Award Program Deadline: Rolling, but LOI required

Multidisciplinary Robert Wood Johnson Foundation Evidence for Action: Innovative Research to Advance Racial Equity Deadline: Rolling; applicant webinar on Oct. 13, 2021, 10 a.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Multidisciplinary Robert Wood Johnson Foundation Evidence for Action: Investigator-Initiated Research to Build a Culture of Health Deadline: Open
This organization is on the President’s List; submit a notice of intent form before applying

Multidisciplinary Robert Wood Johnson Foundation Pioneering Ideas: Exploring the Future to Build a Culture of Health Deadline: Rolling
This organization is on the President’s List; submit a notice of intent form before applying

Neuroscience  SFARI Supplement to Enhance Equity and Diversity (SEED) Deadline: Rolling
This organization is on the President’s List; submit a notice of intent form before applying